ArticleOncology letters2019

Identification of a 3-mRNA signature as a novel potential prognostic biomarker in patients with ovarian serous cystadenocarcinoma in G2 and G3.

Jiahua Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.